Dr. Shashank Joshi

Novo Nordisk India launches world’s first and only GLP-1 RA, Oral Semaglutide- a gamechanger in diabetes

Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an…

2 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420